Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
75.32 USD | -0.92% |
|
+3.61% | -5.60% |
Jun. 05 | Axsome Therapeutics Says It Settled Sunosi Patent Litigation With Unichem Laboratories | MT |
Jun. 05 | RBC Raises Price Target on Axsome Therapeutics to $130 From $127, Keeps Outperform Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.60% | 3.61B | |
+1.43% | 94.45B | |
-1.71% | 38.9B | |
-12.79% | 32.56B | |
-12.23% | 15.98B | |
-1.56% | 13.82B | |
-12.63% | 11.34B | |
+163.45% | 9.81B | |
-53.23% | 9.67B | |
+3.52% | 8.91B |
- Stock Market
- Equities
- AXSM Stock
- News Axsome Therapeutics, Inc.
- Axsome Therapeutics, Inc. Announces Transition of Randall Kaye as Chief Medical Officer to Senior Clinical Advisor